BONE BIOLOGICS CORPORATION Proceeds from Debt, Net of Issuance Costs
BONE BIOLOGICS CORPORATION (BBLG) reported Proceeds from Debt, Net of Issuance Costs of $1.81 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2026-03-02
- BONE BIOLOGICS CORPORATION proceeds from debt, net of issuance costs for the quarter ending 2024-12-31 was $0.00.
- BONE BIOLOGICS CORPORATION proceeds from debt, net of issuance costs for fiscal 2024 was $1.81M.
| Period end | Proceeds from Debt, Net of Issuance Costs 3 month | Proceeds from Debt, Net of Issuance Costs 9 month | Proceeds from Debt, Net of Issuance Costs 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.81M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $1.81M 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |